FIELD: biotechnology.
SUBSTANCE: described is an antibody-drug conjugate (ADC) for delivering a drug to human SEZ6-expressing cells, wherein the conjugate has the structure:
,
wherein the antibody (Ab) contains an anti-SEZ6 antibody with the heavy chain sequence SEQ ID NO: 3 and the light chain sequence SEQ ID NO: 4, and wherein n equals 2.
EFFECT: invention expands the range of means for delivering a drug to human SEZ6-expressing cells.
1 cl, 9 dwg, 6 tbl, 10 ex
| Title | Year | Author | Number |
|---|---|---|---|
| SUBUNIT VACCINE FOR TREATING OR PREVENTING RESPIRATORY TRACT INFECTION | 2020 |
|
RU2811991C2 |
| ANTIBODIES TO IL-6 AND THEIR FUSIONS AND CONJUGATES | 2019 |
|
RU2810777C2 |
| CONJUGATES OF ANTIBODIES TO STAPHYLOCOCCUS AUREUS WITH RIFAMYCIN AND USE THEREOF | 2015 |
|
RU2731055C2 |
| ANTIGENIC POLYPEPTIDES BASED ON THE RESPIRATORY SYNCYTIAL VIRUS SEQUENCE | 2019 |
|
RU2807992C2 |
| SCREENING OF ATTACHMENT SITES WITH FIXED POINT IN CYSTEINE-MODIFIED ANTIBODY-TOXIN (TDC) CONJUGATE | 2018 |
|
RU2816510C2 |
| RSV F MUTANT PROTEIN AND ITS APPLICATION | 2020 |
|
RU2807742C1 |
| MOLECULES BINDING MESOTHELIN AND CD137 | 2019 |
|
RU2815066C2 |
| POLYPEPTIDE LINKER FOR PRODUCTION OF MULTI-SPECIFIC ANTIBODIES | 2018 |
|
RU2776302C2 |
| MODIFIED ANTIBODY CONSTANT REGION | 2021 |
|
RU2797273C2 |
| HPV-SPECIFIC BINDING MOLECULES | 2018 |
|
RU2804664C2 |
